CRITICAL APPRAISAL OF EFFECTIVENESS OF ORAL FINGOLIMOD ON RELAPSING MULTIPLE SCLEROSIS

CRITICAL APPRAISAL OF EFFECTIVENESS OF ORAL FINGOLIMOD ON RELAPSING MULTIPLE SCLEROSIS

Oral fingolimod has been recently accepted as a treatment for relapsing Multiple Sclerosis (MS) by the Indonesian Food and Drug Administration. The number of MS patients is increasing in Indonesia. There is a critical need of systematically reviewing the new medication for both efficacy and safety....

Full description

Bibliographic Details
Main Authors: Rizaldy Taslim Pinzon, Rosa De Lima Renita Sanyasi
Format: Article
Language:English
Published: Universitas Sanata Dharma 2017-11-01
Series:Jurnal Farmasi Sains dan Komunitas
Subjects:
critical appraisal
fingolimod
multiple sclerosis
relapse
Online Access:http://e-journal.usd.ac.id/index.php/JFSK/article/view/606

Similar Items

Similar Items